North Dallas Bank & Trust Co. Takes $913,000 Position in Stryker Corporation $SYK

North Dallas Bank & Trust Co. acquired a new stake in shares of Stryker Corporation (NYSE:SYK) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 2,599 shares of the medical technology company’s stock, valued at approximately $913,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Godfrey Financial Associates Inc. bought a new stake in shares of Stryker during the fourth quarter valued at approximately $26,000. United Financial Planning Group LLC bought a new stake in shares of Stryker during the third quarter valued at approximately $27,000. CGC Financial Services LLC bought a new stake in Stryker in the fourth quarter worth $29,000. Strive Asset Management LLC bought a new stake in Stryker in the third quarter worth $30,000. Finally, ANTIPODES PARTNERS Ltd bought a new stake in Stryker in the third quarter worth $34,000. Institutional investors own 77.09% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on SYK shares. BTIG Research reduced their price target on shares of Stryker from $397.00 to $379.00 and set a “buy” rating on the stock in a research report on Friday, May 1st. The Goldman Sachs Group restated a “neutral” rating and issued a $361.00 price target on shares of Stryker in a research report on Friday, May 1st. Evercore set a $355.00 price target on shares of Stryker in a research report on Friday, May 1st. Wall Street Zen cut shares of Stryker from a “buy” rating to a “hold” rating in a research report on Saturday, May 16th. Finally, JPMorgan Chase & Co. reduced their price target on shares of Stryker from $445.00 to $400.00 and set an “overweight” rating on the stock in a research report on Friday, May 1st. Sixteen equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Stryker presently has a consensus rating of “Moderate Buy” and an average price target of $395.33.

Insiders Place Their Bets

In other Stryker news, VP Robert S. Fletcher sold 4,544 shares of Stryker stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $306.87, for a total transaction of $1,394,417.28. Following the completion of the transaction, the vice president directly owned 10,582 shares of the company’s stock, valued at $3,247,298.34. The trade was a 30.04% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP M Kathryn Fink sold 5,220 shares of Stryker stock in a transaction on Monday, May 11th. The stock was sold at an average price of $283.85, for a total transaction of $1,481,697.00. Following the transaction, the vice president directly owned 13,137 shares of the company’s stock, valued at $3,728,937.45. The trade was a 28.44% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 323,264 shares of company stock valued at $100,659,489 over the last three months. 4.60% of the stock is owned by company insiders.

Stryker Stock Up 4.3%

NYSE SYK opened at $314.41 on Wednesday. The company has a quick ratio of 1.25, a current ratio of 2.11 and a debt-to-equity ratio of 0.62. The company has a fifty day moving average of $317.55 and a two-hundred day moving average of $345.01. The firm has a market capitalization of $120.53 billion, a price-to-earnings ratio of 36.39, a PEG ratio of 1.90 and a beta of 0.78. Stryker Corporation has a 52 week low of $281.00 and a 52 week high of $404.87.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Thursday, April 30th. The medical technology company reported $2.60 EPS for the quarter, missing the consensus estimate of $2.98 by ($0.38). The firm had revenue of $6.02 billion for the quarter, compared to analysts’ expectations of $6.34 billion. Stryker had a return on equity of 23.42% and a net margin of 13.20%.The firm’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.84 earnings per share. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. On average, analysts predict that Stryker Corporation will post 14.98 earnings per share for the current year.

Stryker Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be paid a dividend of $0.88 per share. This represents a $3.52 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend is Tuesday, June 30th. Stryker’s payout ratio is presently 40.74%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.